The progression and stabilization of neurodegenerative diseases are deeply influenced by the balance between NF-κB (a pro-inflammatory mediator) and Nrf2 (a key antioxidant regulator), especially during sleep. Here, NFKB1 is linked to neurodegenerative disease.